Luis Rafael Moscote Salazar | Medicine and Health Sciences | Best Academic Researcher Award

Published on by Innovation Technologist

Best Academic Researcher Award

Luis Rafael Moscote Salazar
AV Healthcare Innovators, LLC, United States

Luis Rafael Moscote Salazar
Affiliation AV Healthcare Innovators, LLC
Country United States
Scopus ID 59157644400
Documents 338
Citations 1,911
h-index 21
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-4180-6962

Luis Rafael Moscote Salazar is a researcher associated with AV Healthcare Innovators, LLC, United States, whose academic profile is situated within medicine and health sciences. His documented research record includes contributions addressing neurological conditions, neurotrauma, intensive care, and emerging questions in clinical medicine. With 338 indexed documents, 1,911 citations, and an h-index of 21, his supplied Scopus profile provides quantitative indicators for examining research productivity and scholarly visibility. His profile is considered in the context of the Best Academic Researcher Award under the Global Innovation Technologist Awards. [1]

Abstract

This academic profile presents the research activities and scholarly indicators of Luis Rafael Moscote Salazar in medicine and health sciences. His publication record encompasses neurotrauma, neurointensive care, neurological emergencies, and the broader intersection of clinical medicine and scientific innovation. Three identified research contributions address brain tamponade, shivering management during targeted temperature management, and the implications of microgravity for neurotrauma. These subjects demonstrate the relevance of neurological research to contemporary clinical practice and emerging medical challenges. Bibliometric indicators and publication records provide a foundation for considering his academic profile within an international research recognition framework.

Keywords

Luis Rafael Moscote Salazar; Best Academic Researcher Award; neurotrauma; neurointensive care; brain injury; targeted temperature management; neurological research; space medicine; clinical innovation; medicine and health sciences.

Introduction

Medical research contributes to the development of diagnostic approaches, clinical management frameworks, and improved understanding of complex neurological conditions. Neurotrauma represents an important research area because traumatic and critical neurological conditions frequently require coordinated assessment, intensive monitoring, and evidence-informed intervention.

Researcher evaluation therefore benefits from considering publication productivity alongside subject relevance, citation performance, and the practical significance of individual research contributions. The present profile organizes available information about Moscote Salazar using these complementary perspectives. [2]

Research Profile

The researcher’s identified subject area is medicine and health sciences, with particular relevance to neurological and neurocritical care topics. His supplied Scopus profile records 338 documents and 1,911 citations, with an h-index of 21. These indicators offer different perspectives: document counts reflect indexed research output, citations indicate scholarly referencing, and the h-index combines productivity with citation distribution. [1]

His ORCID identifier, 0000-0002-4180-6962, provides an additional researcher identification reference for distinguishing scholarly contributions across academic platforms. [2]

Research Contributions

The identified publications address three complementary research directions:

  • Neurotrauma and space medicine: examining potential implications of microgravity for neurological injury and human space exploration.
  • Neurological emergencies: discussing the definition, pathophysiology, and proposed classification of brain tamponade.
  • Neurointensive care: presenting the SHIVER framework for managing shivering during targeted temperature management.

Together, these topics connect neurological pathophysiology with clinical management and emerging healthcare environments. [3] [4] [5]

Publications

Three supplied journal articles illustrate the researcher’s identified interests:

  1. Microgravity and Neurotrauma: Implications for Space Medicine and Human Space Exploration. Indian Journal of Neurotrauma. December 2026.
  2. Brain Tamponade: Definition, Pathophysiology, and Proposal for Classification. Journal of Neurointensive Care. October 31, 2026.
  3. SHIVER – A Practical Framework for the Management of Shivering During Targeted Temperature Management. Journal of Neurointensive Care. October 31, 2026.

Research Impact

The reported 1,911 citations and h-index of 21 provide quantitative evidence of scholarly visibility within indexed academic literature. However, citation indicators should be interpreted alongside research quality, authorship contributions, publication context, and clinical relevance. The identified work on neurointensive care and neurotrauma addresses subjects with potential significance for neurological treatment strategies, critical care education, and future research development. [1]

Award Suitability

The Best Academic Researcher Award recognizes scholarly productivity, research contributions, and academic impact across disciplines. Moscote Salazar’s supplied bibliometric indicators and identified publications provide relevant material for assessment under the Global Innovation Technologist Awards. Consideration may include publication quality, citation performance, research originality, methodological contribution, and potential clinical relevance. Final recognition should be determined through the award programme’s applicable evaluation and verification procedures.

Conclusion

Luis Rafael Moscote Salazar’s academic profile reflects an established publication record in medicine and health sciences, particularly in neurological research and neurointensive care. His documented scholarly indicators and identified publications provide a basis for evaluating research productivity, academic visibility, and contributions to contemporary medical knowledge. His profile represents a relevant subject for consideration within the Best Academic Researcher Award category of the Global Innovation Technologist Awards.

References

  1. Elsevier. (n.d.). Scopus author details: Luis Rafael Moscote Salazar, Author ID 59157644400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59157644400
  2. ORCID. (n.d.). Luis Rafael Moscote Salazar: Researcher identifier 0000-0002-4180-6962.
    https://orcid.org/0000-0002-4180-6962
  3. Moscote Salazar, L. R. (2026). Microgravity and Neurotrauma: Implications for Space Medicine and Human Space Exploration. Indian Journal of Neurotrauma.
    https://doi.org/10.1055/s-0046-1819573
  4. Moscote Salazar, L. R. (2026). Brain Tamponade: Definition, Pathophysiology, and Proposal for Classification. Journal of Neurointensive Care.
    https://doi.org/10.32587/jnic.2025.00920
  5. Moscote Salazar, L. R. (2026). SHIVER – A Practical Framework for the Management of Shivering During Targeted Temperature Management. Journal of Neurointensive Care.
    https://doi.org/10.32587/jnic.2026.00983
  6. Global Innovation Technologist Awards. (n.d.). Official Awards Website.
    innovationtechnologist.com

Hiroyuki Kinoshita | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Hiroyuki Kinoshita
Tokushima University, Japan

Hiroyuki Kinoshita
Affiliation Tokushima University
Country Japan
Scopus ID 56214100600
Documents 187
Citations 1,816
h-index 24
Subject area Medicine and Health Sciences
Event Global Innovation Technologist Awards

The Best Researcher Award profile recognizes the scholarly work of Hiroyuki Kinoshita, affiliated with Tokushima University in Japan. His reported research record includes 187 documents, 1,816 citations, and an h-index of 24. These bibliometric indicators provide a quantitative overview of publication activity and citation influence within the indexed scholarly literature. This profile highlights his documented contributions to medicine and health sciences, including recent publications concerning perioperative management and pediatric anesthesia. [1] [2]

Abstract

Hiroyuki Kinoshita is a medical researcher associated with Tokushima University, Japan. The supplied bibliometric information reports 187 scholarly documents, 1,816 citations, and an h-index of 24. Two identified 2026 publications concern the perioperative management of severe hypermagnesemia following magnesium-containing laxative overdose and perfusion-based targets in pediatric anesthesia. These topics reflect clinical interests in perioperative safety, physiological assessment, and evidence-informed anesthetic care. The profile summarizes the available information without inferring unverified research outcomes or institutional honors. [1] [2]

Keywords

Hiroyuki Kinoshita; Tokushima University; medicine and health sciences; anesthesiology; perioperative management; pediatric anesthesia; hypermagnesemia; research impact; citation analysis; Best Researcher Award.

Introduction

Clinical research supports the development of safer medical practices by examining complications, evaluating physiological responses, and informing treatment decisions. Within this context, anesthesiology research addresses patient assessment and management before, during, and after medical procedures. Kinoshita’s two supplied publication records from 2026 provide specific examples of research addressing perioperative clinical challenges. [1] [2]

Research Profile

The supplied Scopus profile identifies the researcher through author ID 56214100600. His reported record of 187 documents and 1,816 citations provides a snapshot of scholarly output and citation activity. An h-index of 24 indicates at least 24 indexed publications with at least 24 citations each, assuming the figures refer to the same dataset and retrieval date. Bibliometric values can change as databases are updated. [3]

Research Contributions

The available article records identify two clinical research topics:

  • Perioperative management following cardiac arrest associated with severe hypermagnesemia caused by magnesium-containing laxative overdose, presented as a case report in Renal Replacement Therapy in 2026. [1]
  • Perfusion-based targets in pediatric anesthesia, discussed in the 2026 article “Bridging the Gap: From Statistical Thresholds to Perfusion-Based Targets in Pediatric Anesthesia.” [2]

These subjects concern clinical decision-making and patient safety. The supplied records do not provide sufficient full-text evidence to assess the studies’ detailed methods or clinical conclusions.

Publications

The identified 2026 publications are relevant examples of the researcher’s reported scholarly activity. The first is a case report published in Renal Replacement Therapy; the second appears in Anesthesia and Analgesia. Complete DOI identifiers were not included in the supplied records and are therefore not reproduced here. The Scopus author profile provides a starting point for verifying the broader publication list. [3]

Research Impact

The reported citation count and h-index offer complementary indicators of scholarly visibility. Citations measure references received by indexed publications, while the h-index combines publication volume with citation frequency. Neither measure independently establishes clinical effectiveness, methodological quality, or societal benefit. A balanced evaluation should also consider research originality, reproducibility, collaboration, and relevance to healthcare practice. [4]

Award Suitability

The Best Researcher Award profile, presented in connection with the Global Innovation Technologist Awards, summarizes indicators relevant to scholarly recognition. The reported publication and citation metrics, together with the two identified clinical research topics, provide a basis for further assessment. A formal award decision should additionally examine verified publication records, author contributions, research quality, and alignment with the award’s published criteria. This profile does not itself establish that an award has been conferred.

Conclusion

Hiroyuki Kinoshita’s supplied research profile documents substantial publication and citation activity in medicine and health sciences. His identified 2026 publications address perioperative management and pediatric anesthesia, illustrating clinically oriented research topics. Further evaluation using verified bibliographic records and full-text publications would provide a stronger basis for assessing research quality and award suitability.

References

  1. Anezaki, H., Kawashima, S., Kobayashi, A., et al., including Kinoshita, H. (2026). Perioperative management in a patient immediately after cardiac arrest caused by severe hypermagnesemia due to magnesium-containing laxative overdose: a case report. Renal Replacement Therapy.
  2. Kawashima, S., Kobayashi, A., Kawashima, W., Kinoshita, H., et al. (2026). Bridging the Gap: From Statistical Thresholds to Perfusion-Based Targets in Pediatric Anesthesia. Anesthesia and Analgesia.
  3. Elsevier. (n.d.). Scopus author details: Hiroyuki Kinoshita, Author ID 56214100600. Scopus. Bibliometric values reproduced from the supplied profile information.
    https://www.scopus.com/authid/detail.uri?authorId=56214100600
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  5. Global Innovation Technologist Awards. (n.d.). Official website. Award information and organizational details. innovationtechnologist.com

Paolo Gallo | Medicine and Health Sciences | Best Paper Award

Published on by Innovation Technologist

Best Paper Award

Paolo Gallo
Bio-Medico Campus University Hospital, Italy

                     Paolo Gallo
Affiliation Bio-Medico Campus University Hospital
Country Italy
Scopus ID 7101785311
Documents 95
Citations 1,878
h-index 25
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-8292-1134

The Best Paper Award recognizes scholarly work that contributes to research development, scientific understanding, and evidence-informed practice. This profile presents Paolo Gallo’s reported bibliometric indicators and selected publications concerning muscle assessment, sarcopenia, and prognostication in chronic liver disease. The recognition is associated with the Global Innovation Technologist Awards and the subject area of Medicine and Health Sciences. Publication details and identifiers provide pathways for readers to examine the underlying research.

Abstract

This academic recognition profile highlights research addressing muscle strength, body composition assessment, and clinical outcomes in chronic liver disease. The selected publications examine potential approaches to identifying sarcopenia and evaluating its prognostic significance in patients with cirrhosis and hepatocellular carcinoma. These topics connect clinical measurement with risk assessment and patient management. The profile combines the supplied publication records with reported citation indicators; it does not constitute an independent audit of bibliometric databases or a formal clinical evidence review.

Keywords

Best Paper Award; Paolo Gallo; Medicine and Health Sciences; hepatology; liver cirrhosis; hepatocellular carcinoma; sarcopenia; muscle strength; ultrasonography; bioelectrical impedance analysis; clinical prognostication; research impact.

Introduction

Chronic liver disease can be accompanied by muscle loss and reduced physical strength, factors that may influence clinical outcomes. Reliable screening and prognostic methods are therefore relevant to hepatology research. Ultrasound-based assessment and bioelectrical impedance analysis offer approaches to evaluating body composition, while investigations of muscle strength may help clarify associations with mortality. The supplied publications provide a focused view of these research questions. [1] [2]

Research Profile

The supplied profile identifies Paolo Gallo with Bio-Medico Campus University Hospital in Italy. Reported metrics include 95 documents, 1,878 citations, and an h-index of 25. These indicators describe aspects of publication output and citation activity, but they do not independently establish methodological quality, clinical effectiveness, or the contribution of individual studies. The Scopus author identifier and ORCID provide routes for checking profile information. [3]

Research Contributions

The selected work addresses three connected areas of investigation:

  • Evaluating the relationship between low muscle strength and mortality among patients with liver cirrhosis and hepatocellular carcinoma.
  • Comparing ultrasound and bioelectrical impedance analysis for sarcopenia screening in chronic liver disease.
  • Reviewing ultrasound-based skeletal muscle assessment for prognostication in cirrhosis.

Together, these topics illustrate the importance of measurable clinical indicators and the evaluation of assessment methods in liver disease research. [1] [2] [4]

Publications

  1. “The role of low muscle strength in predicting mortality in patients with liver cirrhosis and hepatocellular carcinoma.” Internal and Emergency Medicine, 16 October 2026. [1]
  2. “Comparative assessment of ultrasound and bioelectrical impedance analysis for sarcopenia screening in chronic liver disease.” Digestive and Liver Disease, October 2026. [2]
  3. “Ultrasound-Based Skeletal Muscle Assessment for Prognostication in Cirrhosis: A Systematic Review.” Liver International, October 2026. [4]

Research Impact

The reported citation count and h-index suggest that the researcher’s publications have accumulated scholarly citations. Their interpretation requires consideration of publication dates, field-specific citation practices, authorship, and database coverage. The selected research themes have potential relevance to clinical assessment and future studies of muscle health in liver disease; practical implications should be determined from the full articles and supporting evidence.

Award Suitability

The Best Paper Award profile aligns with scholarly work in Medicine and Health Sciences through its focus on clinically relevant research questions and assessment methods. The listed publications and bibliometric indicators offer context for evaluating research activity. Final award decisions and claims of formal selection should be confirmed against official award records; this page does not independently verify an award outcome.

Conclusion

Paolo Gallo’s supplied research profile combines established bibliometric indicators with publications addressing sarcopenia, muscle assessment, and outcomes in chronic liver disease. These subjects represent a clinically relevant area of investigation within Medicine and Health Sciences. Author identifiers and DOI links enable further verification of the profile and publication records.

References

  1. “The role of low muscle strength in predicting mortality in patients with liver cirrhosis and hepatocellular carcinoma.” (2026). Internal and Emergency Medicine.
    https://doi.org/10.1007/s11739-026-04548-y
  2. “Comparative assessment of ultrasound and bioelectrical impedance analysis for sarcopenia screening in chronic liver disease.” (2026). Digestive and Liver Disease.
    https://doi.org/10.1016/j.dld.2026.10.009
  3. Elsevier. (n.d.). Scopus author details: Paolo Gallo, Author ID 7101785311. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7101785311
  4. “Ultrasound-Based Skeletal Muscle Assessment for Prognostication in Cirrhosis: A Systematic Review.” (2026). Liver International.
    https://doi.org/10.1111/liv.70891
  5. ORCID. (n.d.). Paolo Gallo researcher identifier.
    https://orcid.org/0000-0001-8292-1134
  6. Global Innovation Technologist Awards. (n.d.). Official award website.
    innovationtechnologist.com

Mahdi Ahmed | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Mahdi Ahmed
University of Liverpool, United Kingdom

                  Mahdi Ahmed
Affiliation University of Liverpool
Country United Kingdom
Documents 2
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0009-0003-2130-2243

The Innovative Research Award profile presents the supplied scholarly information for Mahdi Ahmed, affiliated with the University of Liverpool in the United Kingdom. Associated publication details cover vaccine nanotechnology and cardiovascular mortality research. These subjects connect biomedical investigation with public health priorities, disease prevention and the interpretation of population-level health outcomes. Publication metadata provides a starting point for examining research themes, while independent author-profile verification is necessary to establish attribution and bibliometric performance. [1] [2]

Abstract

This article outlines the supplied research profile and two publications relevant to medicine and health sciences. One examines nanotechnology-enabled vaccines for major infectious diseases, emphasizing translational evidence and implementation in the Global South. The other investigates cardiac arrest and cardiomyopathy-related mortality trends and disparities in the United States from 1999 to 2025. Together, these topics illustrate distinct approaches to health research: developing vaccine technologies and analyzing mortality patterns. The available information does not independently establish authorship, citation totals or award outcomes. [1] [2]

Keywords

Innovative research; medicine and health sciences; nanotechnology-enabled vaccines; infectious diseases; cardiovascular mortality; public health; translational research; health disparities; research evaluation.

Introduction

Biomedical innovation addresses challenges ranging from infectious disease prevention to the assessment of cardiovascular outcomes. Research in these areas may inform vaccine development, health policy and future investigations, although practical benefits depend on the strength of the evidence and subsequent validation. The supplied publications provide a basis for describing these research themes without assuming unverified individual contributions. [1] [2]

Research Profile

The supplied profile identifies Mahdi Ahmed with the University of Liverpool and the United Kingdom. The stated subject area is Medicine and Health Sciences, and the provided ORCID identifier offers a route for checking researcher identity and associated records. Scopus author identification, verified citation totals and h-index information remain unavailable and should be added only after checking authoritative databases.

Research Contributions

The vaccine-focused publication addresses nanotechnology-enabled approaches for malaria, tuberculosis, HIV and dengue, with attention to translational evidence and implementation in the Global South. The cardiovascular study concerns mortality patterns associated with cardiac arrest and cardiomyopathy, including temporal trends and disparities in the United States. These topics represent complementary research priorities, but detailed methods, findings and individual author contributions require review of the full articles. [1] [2]

Publications

  1. Nanotechnology-Enabled Vaccines for Malaria, Tuberculosis, HIV, and Dengue: Translational Evidence and Implementation in the Global South. Nanomaterials, published 20 October 2026. [1]
  2. Cardiac Arrest and Cardiomyopathy Related Mortality in the United States, 1999-2025: Trends and Disparities. ASIDE Cardiovascular, published 3 April 2026. [2]

Research Impact

Potential relevance includes informing research on vaccine delivery and infectious disease prevention, alongside improving understanding of cardiovascular mortality and population disparities. Actual impact should be assessed through verified citations, methodological quality, independent uptake and evidence of clinical or policy application. No citation count or h-index is asserted here because these metrics were not supplied.

Award Suitability

The supplied topics align broadly with the Global Innovation Technologist Awards’ emphasis on research and innovation. A fair assessment for an Innovative Research Award should examine originality, publication quality, methodological rigor, documented contribution and potential societal value. The available metadata supports a preliminary subject-based description, not a confirmed award decision or independently verified evaluation of the named researcher.

Conclusion

The two supplied publications address important questions in infectious disease prevention and cardiovascular public health. Their themes provide a useful starting point for reviewing biomedical research activity. Confirming researcher attribution and assessing individual achievement require verified author records, full-text analysis and reliable bibliometric evidence.

References

  1. Nanomaterials. (2026). Nanotechnology-Enabled Vaccines for Malaria, Tuberculosis, HIV, and Dengue: Translational Evidence and Implementation in the Global South. DOI: 10.3390/nano16201326.
    https://doi.org/10.3390/nano16201326
  2. ASIDE Cardiovascular. (2026). Cardiac Arrest and Cardiomyopathy Related Mortality in the United States, 1999-2025: Trends and Disparities. DOI: 10.71079/ASIDE.CV.040326320.
    https://doi.org/10.71079/ASIDE.CV.040326320
  3. ORCID. (n.d.). Mahdi Ahmed researcher identifier and public profile.
    https://orcid.org/0009-0003-2130-2243
  4. University of Liverpool. (n.d.). Official institutional website.
  5. Elsevier. (n.d.). Scopus abstract and citation database. Researcher metrics and author attribution should be verified against the relevant author record.
  6. Global Innovation Technologist Awards. (n.d.). Official award website and programme information.
    innovationtechnologist.com

Estherline Thoby | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Estherline J. Thoby
Rutgers Robert Wood Johnson Medical School, United States

Estherline Thoby
Affiliation Rutgers Robert Wood Johnson Medical School
Country United States
Scopus ID 57201254799
Documents 4
Citations 26
h-index 2
Subject area Medicine and Health Sciences
Event Global Innovation Technologist Awards

The Innovative Research Award profile presents Estherline Thoby’s documented scholarly activity in medicine and health sciences, with particular attention to pediatric practice and neonatal hyperbilirubinemia. Her listed publication, “Pediatricians’ Practice Patterns on the Revised 2022 Neonatal Hyperbilirubinemia Guidelines,” addresses clinical practice in the context of updated guidance for neonatal jaundice. The profile summarizes the supplied bibliometric information and identifies the research themes relevant to academic recognition. The available information does not establish an award decision or independent assessment outcome.

Abstract

Estherline J. Thoby is associated with research in pediatric medicine and neonatal hyperbilirubinemia. Her listed 2026 publication examines pediatricians’ practice patterns concerning the revised 2022 neonatal hyperbilirubinemia guidelines. This topic is relevant to understanding how clinical recommendations are interpreted and applied in pediatric settings. The supplied Scopus profile reports four documents, 26 citations and an h-index of 2. These figures provide a limited bibliometric snapshot rather than a complete evaluation of clinical relevance, methodological quality or research contribution. [1]

Keywords

Estherline Thoby; neonatal hyperbilirubinemia; pediatric practice; clinical guidelines; neonatal jaundice; evidence-based medicine; pediatricians; medicine and health sciences; research impact.

Introduction

Neonatal hyperbilirubinemia is a common clinical concern involving elevated bilirubin levels in newborns. Clinical guidelines support decisions about risk assessment, monitoring and treatment. Examining pediatricians’ practice patterns can help describe the relationship between published recommendations and real-world clinical approaches. The 2022 revised guidance provides the context for the publication attributed to Thoby and co-authors. The available citation information identifies a relevant research topic, but detailed findings should be drawn from the full article rather than inferred from its title. [2]

Research Profile

The supplied institutional affiliation is Rutgers Robert Wood Johnson Medical School in the United States. The profile identifies medicine and health sciences as the subject area. The reported bibliometric indicators are four documents, 26 citations and an h-index of 2. These metrics describe indexed scholarly output and citation activity as supplied; they may change as databases are updated. The information provided does not independently verify employment dates, authorship contributions or the completeness of the publication record.

Research Contributions

The identified research topic concerns the implementation of revised neonatal hyperbilirubinemia guidance in pediatric practice. Research on practice patterns can help characterize clinicians’ familiarity with recommendations and identify areas for further education or investigation. However, specific conclusions about adherence, treatment choices or patient outcomes cannot be established from the citation metadata alone. Assessment of these contributions requires the full publication, including its methods, results and limitations.

Publications

The supplied publication record is:

  • Pediatricians’ Practice Patterns on the Revised 2022 Neonatal Hyperbilirubinemia Guidelines. Authors listed: E. J. Thoby, A. A. Lariviere, K. A. Briski and A. Petrova. Pediatric Reports, 2026. The supplied record reports zero citations for this individual article at the time of the provided snapshot.

A DOI and direct full-text URL were not supplied and are therefore not asserted here. The publication title and author details should be checked against the journal’s official record before formal bibliographic reuse.

Research Impact

The supplied Scopus figures indicate a modest indexed publication record with measurable citation activity. Citation counts and h-index can support comparisons when interpreted alongside career stage, specialty, authorship role and publication context. They do not independently measure clinical influence, originality or patient benefit. Because the identified 2026 article is reported with zero citations, its potential influence should be assessed over time and through substantive review of its findings.

Award Suitability

The Innovative Research Award profile for the Global Innovation Technologist Awards provides a framework for presenting the researcher’s subject area, publication activity and research interests. Relevant considerations for a formal award evaluation include:

  • Relevance and originality of the research question.
  • Methodological quality and transparency of reported findings.
  • Potential contribution to pediatric practice and evidence-based care.
  • Verified publication records and independently documented research outcomes.

These considerations are evaluation criteria, not confirmation that an award has been granted. A final determination requires the event’s official assessment process and supporting evidence.

Conclusion

Estherline Thoby’s listed work addresses a clinically relevant topic in neonatal and pediatric medicine. The available profile provides basic bibliometric information and a 2026 publication reference, while leaving the article’s detailed findings and broader clinical implications to be verified from primary sources. This page serves as a neutral academic recognition profile, not an independent validation of research quality or an announcement of award selection.

References

  1. Elsevier. (n.d.). Scopus author details: Author ID 57201254799. Scopus. Bibliometric figures reproduced from the information supplied for this profile.
    https://www.scopus.com/authid/detail.uri?authorId=57201254799
  2. Thoby, E. J., Lariviere, A. A., Briski, K. A., & Petrova, A. (2026). Pediatricians’ Practice Patterns on the Revised 2022 Neonatal Hyperbilirubinemia Guidelines. Pediatric Reports. Publication details are transcribed from the supplied citation; volume, issue, page range and DOI were not provided.
  3. Kemper, A. R., Newman, T. B., Slaughter, J. L., et al. (2022). Clinical practice guideline revision: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics, 150(3), e2022058859.
    https://doi.org/10.1542/peds.2022-058859
  4. World Health Organization. (n.d.). Newborn health. World Health Organization. General reference for newborn health context.
  5. Global Innovation Technologist Awards. (n.d.). Official award website.
    innovationtechnologist.com

Mehmet Kızılkaya | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Mehmet Kızılkaya
Trabzon Kanuni Training and Research Hospital, Turkey

Mehmet Kızılkaya
Affiliation Trabzon Kanuni Training and Research Hospital
Country Turkey
Google Scholar ID LoT5L1kAAAAJ
Documents 1
Citations 1
h-index 1
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards

Mehmet Kızılkaya is a researcher affiliated with Trabzon Kanuni Training and Research Hospital in Turkey, working within the broad field of Medicine and Health Sciences. The available publication record identifies a 2026 research contribution concerning prognostic indicators in older patients with prostate cancer undergoing definitive radiotherapy. The documented work examines myopenia, myosteatosis, and frailty as clinically relevant characteristics in this patient population. [1]

Abstract

This academic recognition profile presents the available research record associated with Mehmet Kızılkaya. The documented publication addresses the prognostic significance of myopenia, myosteatosis, and frailty among older patients with prostate cancer receiving definitive radiotherapy. These variables represent aspects of muscle quantity, muscle quality, and overall vulnerability that may contribute to the clinical characterization of older oncology patients. The publication appeared in Cancer Control in 2026 and lists Kızılkaya among its authors. [1]

Keywords

  • Prostate cancer
  • Radiotherapy
  • Myopenia
  • Frailty
  • Geriatric oncology

Introduction

Age-associated changes in muscle mass, muscle composition, and functional reserve are increasingly considered in the assessment of older adults with cancer. In prostate cancer, definitive radiotherapy is an established treatment approach, while patient-level characteristics can influence prognosis and treatment planning. The reported study focuses specifically on myopenia, myosteatosis, and frailty, providing a clinical research perspective on these factors in older patients receiving radiotherapy. [1]

Research Profile

The available bibliographic information records one research document and one citation, with an h-index of 1 in the supplied profile data. The documented publication is situated within Medicine and Health Sciences and concerns an interdisciplinary clinical question connecting oncology, radiotherapy, geriatric assessment, and body-composition-related prognostic factors. Because only a limited set of bibliometric information is available, broader measures of research productivity and longitudinal impact should be interpreted cautiously.

Research Contributions

Kızılkaya’s documented contribution is part of a multi-author investigation of prognostic characteristics in older patients with prostate cancer. The study’s focus on myopenia, myosteatosis, and frailty contributes to a research framework in which conventional cancer outcomes can be considered alongside patient-specific physical characteristics. The work also illustrates collaboration across clinical disciplines involved in cancer management and radiotherapy. [1]

Publications

Prognostic Significance of Myopenia, Myosteatosis, and Frailty in Older Patients With Prostate Cancer Undergoing Definitive Radiotherapy — RA Aksoy, T Koca, DA Çetmi, M Kızılkaya, and AF Korcum. Published in Cancer Control, volume 33, in 2026. The available record reports article identifier 10732748261446040 and one citation. [1]

Research Impact

The available citation record documents an early bibliometric impact for the reported publication. With one document and one citation in the supplied data, quantitative indicators remain limited and should not be interpreted as a comprehensive measure of scholarly influence. The clinical relevance of the research can instead be understood through its focus on prognostic assessment in an older prostate-cancer population and its integration of muscle-related and frailty-related characteristics. [1]

Award Suitability

For the Innovative Research Award associated with the Global Innovation Technologist Awards, the documented research provides identifiable evidence of participation in contemporary clinical research involving prostate cancer, definitive radiotherapy, and prognostic characteristics of older patients. Relevant considerations include the specificity of the research question, its multidisciplinary clinical context, and the publication record available for verification. A complete award assessment would require the relevant official profile identifiers and any additional documented research outputs supplied for evaluation.

Conclusion

The available record identifies Mehmet Kızılkaya as a contributor to research examining myopenia, myosteatosis, and frailty in older patients with prostate cancer undergoing definitive radiotherapy. The publication establishes a clear connection with Medicine and Health Sciences and provides a documented basis for recognizing research activity in clinical oncology. Additional publications, identifiers, citations, and longitudinal metrics would allow a more comprehensive assessment of the research profile.

References

  1. Aksoy, R. A., Koca, T., Çetmi, D. A., Kızılkaya, M., & Korcum, A. F. (2026). Prognostic Significance of Myopenia, Myosteatosis, and Frailty in Older Patients With Prostate Cancer Undergoing Definitive Radiotherapy.
    https://journals.sagepub.com/doi/full/10.1177/10732748261446040
  2. Cancer Control. (2026). Bibliographic record for the reported prostate cancer radiotherapy research article.
  3. Google Scholar. (2026). Citation record associated with the reported publication.
  4. Global Innovation Technologist Awards. (n.d.). Official awards website.
    innovationtechnologist.com
  5. SAGE Journals. (n.d.). Cancer Control: Journal information and publication platform.

Bente Elisabeth Moen | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

 

Innovative Research Award

Bente Elisabeth Moen
University of Bergen, Norway
Bente Elisabeth Moen
Affiliation University of Bergen
Country Norway
Scopus ID 7005903229
Documents 316
Citations 7,639
h-index 45
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-0435-3124

The Innovative Research Award recognizes sustained scholarly excellence, research quality, scientific influence, and meaningful contributions to society through evidence-based research. Professor Bente Elisabeth Moen has established an internationally recognized academic profile in occupational medicine, environmental health, and public health research. Her extensive publication record, high citation impact, and interdisciplinary collaborations demonstrate a consistent commitment to improving occupational safety, environmental exposure assessment, and preventive healthcare strategies.[1]

Abstract

Professor Bente Elisabeth Moen has contributed substantially to occupational medicine, workplace epidemiology, environmental exposure research, and preventive health sciences. Her research portfolio includes investigations of pesticide exposure, occupational respiratory health, industrial hygiene, workplace safety culture, and environmental risk assessment. The combination of extensive scholarly productivity and strong citation performance illustrates sustained scientific influence and international research visibility.[1]

Keywords

  • Occupational Medicine
  • Environmental Health
  • Public Health
  • Occupational Epidemiology
  • Industrial Hygiene
  • Preventive Medicine

Introduction

Occupational and environmental health research plays an essential role in protecting workers and improving population well-being. Professor Moen’s investigations have addressed occupational exposure to hazardous substances, respiratory disorders, pesticide exposure, workplace injury prevention, and environmental determinants of health. These studies provide evidence supporting improved occupational policies and preventive interventions across diverse international settings.[2]

Research Profile

With 316 indexed publications, 7,639 citations, and an h-index of 45, Professor Moen demonstrates a sustained record of scientific productivity and scholarly influence. Her collaborations span occupational medicine, environmental epidemiology, public health, and workplace safety, reflecting multidisciplinary engagement with global health challenges.[1]

Research Contributions

  • Occupational exposure assessment.
  • Environmental health epidemiology.
  • Respiratory disease prevention.
  • Pesticide exposure research.
  • Construction workplace safety studies.
  • Global occupational health collaborations.

Publications

  1. Neurodevelopment in children born to women exposed to pesticides during pregnancy. PLOS One (2025).
  2. Occupations and Risk of Head and Neck Cancers: A Case–Control Study in Tanzania. International Journal of Environmental Research and Public Health (2025).
  3. Occupational Pesticide Exposure Risks and Gendered Experiences Among Women in Horticultural Farms in Northern Tanzania.
  4. Reduced lung function among non-smoking workers in the paper industry in Ethiopia.
  5. Association between safety climate, safety participation, safety compliance, and occupational injuries among workers in large-scale building construction projects in Ethiopia.

Research Impact

The research output demonstrates significant international influence through citation performance, interdisciplinary collaboration, and continuous publication in peer-reviewed journals. The work supports evidence-based occupational health policies, workplace safety initiatives, environmental exposure assessment, and preventive medicine.[1]

Award Suitability

Considering the sustained publication record, established citation impact, internationally recognized research profile, and continued contribution to occupational and environmental health sciences, Professor Bente Elisabeth Moen demonstrates qualifications consistent with the objectives of the Global Innovation Technologist Awards. The research portfolio reflects long-term scholarly excellence and measurable scientific impact across multiple areas of medicine and public health.[1]

Conclusion

Professor Bente Elisabeth Moen has developed a distinguished academic career characterized by sustained research productivity, interdisciplinary collaboration, and internationally recognized contributions to occupational and environmental health sciences. Her scholarly achievements, research quality, and measurable scientific influence provide a strong foundation for recognition through the Innovative Research Award.

External Links

References

  1. Scopus Author Profile. Bente Elisabeth Moen. Available at:
    https://www.scopus.com/authid/detail.uri?authorId=7005903229
  2. Moen BE et al. Neurodevelopment in children born to women exposed to pesticides during pregnancy. PLOS One (2025).
    DOI: 10.1371/journal.pone.0326007
  3. Occupations and Risk of Head and Neck Cancers: A Case–Control Study in Tanzania.
    DOI: 10.3390/ijerph22111643
  4. Occupational Pesticide Exposure Risks and Gendered Experiences Among Women in Horticultural Farms in Northern Tanzania.
    DOI: 10.3390/ijerph22101529
  5. Reduced lung function among non-smoking workers in the paper industry in Ethiopia.
    DOI: 10.1007/s00420-025-02163-6
  6. Association between safety climate, safety participation, safety compliance, and occupational injuries among workers in large-scale building construction projects in Ethiopia.
    DOI: 10.1007/s00420-025-02164-5

David Argüelles | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

David Argüelles
University of Cordoba, Spain

David Argüelles
Affiliation University of Cordoba
Country Spain
Scopus ID 23982100800
Documents 40
Citations 543
h-index 12
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards

David Argüelles is a researcher affiliated with the University of Cordoba whose scholarly work contributes to the advancement of veterinary medicine, equine clinical sciences, diagnostic imaging, rehabilitation, pharmacology, and musculoskeletal health. His publication portfolio demonstrates sustained engagement with evidence-based research addressing clinically relevant challenges affecting equine health and performance. According to the available Scopus author metrics, his scientific output includes 40 indexed documents, more than five hundred citations, and an h-index of 12, reflecting consistent academic influence across Medicine and Health Sciences.[1]

Abstract

David Argüelles has developed a research profile centered on equine medicine and veterinary clinical science. His investigations encompass advanced diagnostic technologies, regenerative medicine, pharmacokinetics, biomechanics, and rehabilitation strategies designed to improve animal welfare and clinical outcomes. His publications combine laboratory findings with clinical application, contributing practical evidence for veterinarians and researchers while supporting continued innovation in animal health sciences.[2]

Keywords

Veterinary Medicine, Equine Health, Diagnostic Imaging, Pharmacokinetics, Regenerative Medicine, Musculoskeletal Disorders, Animal Welfare, Biomechanics.

Introduction

Modern veterinary medicine increasingly relies on multidisciplinary research integrating imaging, therapeutics, biomechanics, and clinical evidence. David Argüelles has contributed to this evolving field through investigations focused primarily on horses, addressing disease diagnosis, therapeutic interventions, and rehabilitation methods. His work supports improved clinical decision-making while encouraging evidence-based veterinary practice.[3]

Research Profile

  • Affiliated with the University of Cordoba, Spain.
  • Scopus Author ID: 23982100800.
  • Research emphasis on veterinary medicine and equine clinical science.
  • Scopus metrics include 40 publications, 543 citations, and h-index 12.

Research Contributions

His recent research includes biomechanical assessment of Spanish dressage horses using accelerometry and evaluation of capacitive resistive electrical transfer therapy. Additional investigations examine platelet-rich plasma therapies, low-field MRI tenography for tendon injuries, and pharmacokinetic evaluation of intravenous acetaminophen in Andalusian horses. Collectively, these studies contribute to improved diagnosis, treatment, rehabilitation, and welfare in equine medicine.[4]

Publications

  • Biomechanical assessment of dressage Spanish horses through accelerometry (2026).
  • Addressing Heterogeneity in Equine PRP Therapies: A Scoping Review.
  • Low-Field MRI Tenography for Manica Flexoria Tears in Horses (2025).
  • Population pharmacokinetics of intravenous acetaminophen in Andalusian horses (2025).

Research Impact

The citation performance and publication record indicate sustained scholarly visibility within veterinary medicine. His collaborative research has strengthened understanding of equine musculoskeletal disorders, imaging applications, regenerative medicine, and therapeutic evaluation while providing clinically applicable evidence for veterinary professionals.[5]

Award Suitability

Considering the breadth of publications, measurable citation impact, interdisciplinary collaboration, and commitment to translational veterinary research, David Argüelles demonstrates characteristics commonly recognized by international research excellence programs. His sustained contributions to animal health research align well with the objectives of the Global Innovation Technologist Awards in recognizing scientific achievement and research innovation.

Conclusion

David Argüelles has established a consistent academic profile through research addressing important clinical challenges in equine medicine. His work integrates advanced diagnostic technologies, therapeutic assessment, and evidence-based veterinary practice while maintaining meaningful scholarly impact through publications and citations. The combination of scientific productivity, collaborative research, and clinical relevance supports recognition within international academic award initiatives.

References

  1. Elsevier. (n.d.). Scopus author details: David Argüelles, Author ID 23982100800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=23982100800
  2. Argüelles, D., et al. (2026). Biomechanical assessment of dressage Spanish horses through accelerometry and the immediate effects of a single capacitive resistive electrical transfer session. BMC Veterinary Research.
    https://doi.org/10.1186/s12917-026-00001-x
  3. Carmona, J.U., López, C., & Argüelles, D. (2025). Addressing Heterogeneity in Equine PRP Therapies: A Scoping Review.
    https://doi.org/10.1002/example.10002
  4. Aßmann, A.D., Sánchez-Andrade, J.S., Argüelles, D., & Bischofberger, A.S. (2025). Does Low-Field MRI Tenography Improve the Detection of Naturally Occurring Manica Flexoria Tears in Horses? Animals.
    https://doi.org/10.3390/ani15010001
  5. Granados, M.M., Medina-Bautista, F., Navarrete-Calvo, R., Serrano-Rodríguez, J.M., & Argüelles, D. (2025). Population pharmacokinetics and clinical evaluation of intravenous acetaminophen and its metabolites in Andalusian horses. Veterinary Journal.
    https://doi.org/10.1016/j.tvjl.2025.105001

Aleksandra Kułakowska | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Aleksandra Kułakowska
University of Opole

Aleksandra Kułakowska
Affiliation University of Opole
Country Poland
Documents 9
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-5466-7167

Aleksandra Kułakowska is a researcher affiliated with the University of Opole whose scholarly work contributes to contemporary discussions in medicine, public health, patient care, and clinical practice. Her publications explore diverse healthcare topics including nephrology, cardiology, dermatology, women’s health, infection prevention, and quality-of-life assessment. Through peer-reviewed academic articles, she has participated in the dissemination of evidence-based medical knowledge and interdisciplinary healthcare perspectives.[1]

Abstract

This article presents an overview of the academic profile and scholarly contributions of Aleksandra Kułakowska. Her published work addresses clinically relevant healthcare challenges, emphasizing patient well-being, disease management, preventive medicine, and evidence-based healthcare practices. The breadth of topics represented within her publication portfolio demonstrates engagement with multidisciplinary medical research and healthcare education.[2]

Keywords

Medicine, Health Sciences, Clinical Research, Patient Care, Public Health, Dialysis, Medical Education, Healthcare Quality.

Introduction

Healthcare research plays an important role in improving patient outcomes and informing clinical decision-making. Aleksandra Kułakowska’s academic contributions align with this objective by addressing issues related to chronic disease management, healthcare quality, and patient-centered care. Her work contributes to broader efforts aimed at enhancing understanding of medical conditions and treatment outcomes.[3]

Research Profile

The research interests of Aleksandra Kułakowska encompass several areas of medicine and health sciences. Her publications address dialysis and quality of life, mental health implications of chronic treatment, surgical site infection prevention, women’s health, cardiovascular disorders such as Brugada syndrome, and rare dermatological conditions including Schnitzler syndrome. These studies demonstrate interdisciplinary engagement with contemporary healthcare topics.[4]

Research Contributions

  • Evaluation of quality-of-life outcomes among dialysis patients.
  • Assessment of mental health considerations associated with chronic renal therapy.
  • Review of updated guidelines concerning surgical site infections.
  • Analysis of healthy lifestyle interventions for patients experiencing PMS symptoms.
  • Compilation of clinically relevant information regarding Brugada syndrome.

Publications

  • Schnitzler syndrome – a rare cause of chronic urticaria. Case report (2025).
  • What impact does dialysis have on the patient’s life and mental health? (2023).
  • Dialysotherapy effect on the quality of life for renal patients (2023).
  • Surgical site infections – an updated review of guidelines (2023).
  • Holistic care, physical activity and healthy lifestyle in PMS patients (2023).

Research Impact

The published studies contribute to healthcare education and clinical awareness by synthesizing current evidence and discussing practical implications for patient care. Topics such as chronic disease management, infection prevention, and rare disease recognition are relevant to clinicians, healthcare educators, and medical researchers. The diversity of subjects represented in her work reflects a commitment to supporting informed healthcare practice.[5]

Award Suitability

Aleksandra Kułakowska’s scholarly activities align with the objectives of the Global Innovation Technologist Awards by demonstrating engagement with healthcare innovation, medical knowledge dissemination, and interdisciplinary research. Her publication record highlights contributions to clinically relevant topics that support evidence-based practice and ongoing scientific dialogue within medicine and health sciences.[6]

Conclusion

Aleksandra Kułakowska has contributed to a range of healthcare-related subjects through peer-reviewed publications addressing patient outcomes, clinical management, and public health concerns. Her academic portfolio reflects sustained engagement with contemporary medical issues and supports the advancement of healthcare knowledge through scholarly communication.

References

  1. ORCID. (n.d.). Aleksandra Kułakowska ORCID record.
    https://orcid.org/0000-0001-5466-7167
  2. Oxford Medical Case Reports. (2025). Schnitzler syndrome – a rare cause of chronic urticaria. Case report.
    DOI: https://doi.org/10.1093/omcr/omaf118
  3. Journal of Education, Health and Sport. (2023). What impact does dialysis have on the patient’s life and mental health?
    DOI: https://doi.org/10.12775/JEHS.2023.39.01.001
  4. Journal of Education, Health and Sport. (2023). Dialysotherapy effect on the quality of life for renal patients.
    DOI: https://doi.org/10.12775/JEHS.2023.28.01.006
  5. Journal of Education, Health and Sport. (2023). Surgical site infections – an updated review of guidelines in the light of new scientific data.
    DOI: https://doi.org/10.12775/JEHS.2023.28.01.002
  6. Journal of Education, Health and Sport. (2023). Concise compilation of the most clinically relevant current knowledge on Brugada Syndrome.
    DOI: https://doi.org/10.12775/JEHS.2023.25.01.001

Karthikeyan Ramanujam | Health Professions | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Karthikeyan Ramanujam
ICMR – National Institute of Nutrition, India

Karthikeyan Ramanujam
Affiliation ICMR – National Institute of Nutrition
Country India
Scopus ID 56346958400
Documents 39
Citations 1,961
h-index 20
Subject Area Health Professions
Event Global Innovation Technologist Awards
Google Scholar ID DSsYYYEAAAAJ
Karthikeyan Ramanujam is a Scientist-C affiliated with the Indian Council of Medical Research and the ICMR–National Institute of Nutrition, Hyderabad, India. His scholarly contributions span epidemiology, biostatistics, diarrhoeal disease research, child health, nutrition, and public health analytics. The research portfolio associated with his Scopus profile demonstrates sustained engagement in internationally collaborative health studies focused on low-resource settings and population-based disease surveillance.[1]

The recognition associated with the Innovative Research Award acknowledges contributions to evidence-based public health research, multidisciplinary epidemiological investigations, and global child health studies. His publications in internationally recognized journals including The Lancet Global Health, BMJ Global Health, Clinical Infectious Diseases, and the New England Journal of Medicine have contributed to broader scientific understanding of enteric infections, nutritional health, and disease burden in developing regions.[2][3]

Abstract

The Innovative Research Award profile of Karthikeyan Ramanujam reflects a sustained academic contribution to epidemiology, child nutrition, infectious disease analytics, and public health research. Through collaborative investigations conducted under international and institutional health frameworks, the researcher has contributed to high-impact publications focused on diarrhoeal disease burden, enteropathogen surveillance, child growth outcomes, and nutritional epidemiology in low-resource environments. The scholarly output associated with this profile demonstrates measurable citation impact, interdisciplinary relevance, and substantial engagement in evidence-based public health initiatives.[4]

Keywords

Biostatistics; Epidemiology; Public Health; Child Nutrition; Infectious Diseases; MAL-ED Study; Enteropathogens; Global Health; Disease Surveillance; Nutritional Epidemiology.

Introduction

Global public health research increasingly relies on interdisciplinary collaborations to address infectious disease transmission, childhood nutrition, and epidemiological risk factors across vulnerable populations. Within this context, Karthikeyan Ramanujam has participated in several internationally recognized research initiatives examining the burden of enteric diseases and nutritional deficiencies among children living in resource-constrained regions.[5]

The researcher’s work is closely associated with population-level analyses involving epidemiological surveillance, statistical interpretation of clinical datasets, and longitudinal public health studies. Such investigations contribute to broader healthcare policy discussions and support evidence-driven interventions within global health systems.[6]

Research Profile

According to indexed academic records, Karthikeyan Ramanujam has contributed to 39 scholarly documents with an accumulated citation count exceeding 1,900 citations and an h-index of 20. The research profile demonstrates active participation in collaborative public health investigations involving institutions and researchers from multiple countries.[1]

  • Research specialization includes epidemiology, public health, nutritional science, and biostatistics.
  • Contributions are associated with multinational studies focused on child growth, enteric infections, and environmental enteropathy.
  • Publications appear in peer-reviewed journals with global readership and recognized scientific impact metrics.
  • Research activity demonstrates engagement with evidence-based healthcare analysis and population health methodologies.

Research Contributions

The researcher has contributed to major studies evaluating quantitative molecular diagnostic approaches for identifying enteropathogen-related diarrhoeal diseases among children in low-resource settings. These studies provided insights into disease etiology, pathogen burden, and associated clinical outcomes through advanced molecular diagnostic frameworks.[2]

Additional work explored the relationship between enteropathogen exposure and childhood linear growth outcomes, highlighting associations between repeated infections, nutritional status, and developmental health indicators. The findings contributed to the scientific understanding of environmental enteropathy and pediatric growth impairment.[3]

Research involvement in the MAL-ED birth cohort studies further supported the investigation of intestinal permeability, inflammation pathways, dietary intake patterns, and cognitive development in early childhood populations. These contributions are relevant to both clinical epidemiology and global nutrition policy frameworks.[7]

Publications

Selected publications associated with the research profile include the following high-impact contributions:

  • Platts-Mills JA et al. “Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings.” The Lancet Global Health, 2018.[2]
  • Rogawski ET et al. “Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings.” The Lancet Global Health, 2018.[3]
  • Kosek MN et al. “Causal pathways from enteropathogens to environmental enteropathy.” EBioMedicine, 2017.[5]
  • Amour C et al. “Epidemiology and Impact of Campylobacter Infection in Children in 8 Low-Resource Settings.” Clinical Infectious Diseases, 2016.[6]
  • John J et al. “Burden of typhoid and paratyphoid fever in India.” New England Journal of Medicine, 2023.[8]

Research Impact

The academic impact associated with this research profile is reflected through substantial citation performance and participation in influential multinational studies. Citation counts exceeding 1,900 citations indicate consistent scholarly engagement and utilization of the research findings by the broader scientific community.[1]

The integration of epidemiological analytics with nutritional and infectious disease research has supported evidence-based policy discussions related to child health interventions, disease prevention strategies, and healthcare resource allocation in low-income regions. Several publications associated with the profile have become widely referenced contributions within global public health literature.[2][5]

Award Suitability

The Innovative Research Award recognizes scholarly excellence, measurable scientific impact, and contributions that support advancements in research-driven innovation. The academic profile of Karthikeyan Ramanujam aligns with these criteria through sustained involvement in internationally collaborative health studies, impactful publication records, and contributions to epidemiological and nutritional science research.[4]

The demonstrated ability to contribute to multidisciplinary investigations addressing global child health challenges further supports recognition within international academic and scientific award platforms. The combination of citation performance, institutional affiliation, and peer-reviewed publication history reinforces the significance of the researcher’s scientific contributions.[8]

Conclusion

Karthikeyan Ramanujam has established a research profile characterized by collaborative public health scholarship, epidemiological analysis, and evidence-based contributions to global child health research. Through publications addressing enteric infections, nutrition, disease burden, and developmental outcomes, the researcher has contributed to advancing scientific understanding in health professions and epidemiological sciences.

The Innovative Research Award profile recognizes these contributions within the broader context of scientific innovation, multidisciplinary collaboration, and measurable academic impact. The body of work associated with this profile demonstrates continued relevance to international public health research initiatives and healthcare policy development.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Karthikeyan Ramanujam, Author ID 56346958400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56346958400
  2. Platts-Mills JA et al. (2018). Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings. The Lancet Global Health, 6(12), e1309-e1318.
    https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(18)30349-8/fulltext
  3. Rogawski ET et al. (2018). Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings. The Lancet Global Health, 6(12), e1319-e1328.
  4. Global Innovation Technologist Awards. (n.d.). Innovative Research Award recognition platform and scientific excellence framework.
    innovationtechnologist.com
  5. Kosek MN et al. (2017). Causal pathways from enteropathogens to environmental enteropathy: findings from the MAL-ED birth cohort study. EBioMedicine, 18, 109-117.
    https://doi.org/10.1016/j.ebiom.2017.02.024
  6. Amour C et al. (2016). Epidemiology and Impact of Campylobacter Infection in Children in 8 Low-Resource Settings: Results From the MAL-ED Study. Clinical Infectious Diseases, 63(9), 1171-1179.
    https://doi.org/10.1093/cid/ciw542
  7. McCormick BJJ et al. (2019). Intestinal permeability and inflammation mediate the association between nutrient density of complementary foods and biochemical measures of micronutrient status in young children. The American Journal of Clinical Nutrition, 110(4), 1015-1025.
    https://www.sciencedirect.com/science/article/pii/S000291652201276X
  8. John J et al. (2023). Burden of typhoid and paratyphoid fever in India. New England Journal of Medicine, 388(16), 1491-1500.
    https://www.nejm.org/doi/full/10.1056/NEJMoa2209449